The Role of the Kidneys and Liver in the Elimination of Glucagon

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

March 28, 2023

Study Completion Date

March 28, 2023

Conditions
Chronic Kidney DiseasesLiver CirrhosisHyperglucagonemia
Interventions
BIOLOGICAL

Glucagon infusion

One hour glucagon-clamp followed by one hour of blood sampling

BIOLOGICAL

Primed tracer infusion

Infusion of primed isotopically labelled glucose, amino acids and lipids. From 2 hours prior to glucagon infusion and throughout the test day,

Trial Locations (1)

2900

Center for Clinical Metabolic Research, Department of Medicine, Gentofte Hospital, Hellerup

All Listed Sponsors
collaborator

The Novo Nordisk Foundation Center for Basic Metabolic Research

OTHER

lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT05056584 - The Role of the Kidneys and Liver in the Elimination of Glucagon | Biotech Hunter | Biotech Hunter